These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20190369)

  • 21. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain.
    Sumner BE; Grant KE; Rosie R; Hegele-Hartung Ch; Fritzemeier KH; Fink G
    Neurosci Lett; 2007 Apr; 417(1):95-9. PubMed ID: 17398000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men.
    Doran PM; Riggs BL; Atkinson EJ; Khosla S
    J Bone Miner Res; 2001 Nov; 16(11):2118-25. PubMed ID: 11697809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical experience with raloxifene].
    Szúcs J; Pávó I; Jurida N
    Orv Hetil; 2000 Jan; 141(5):237-40. PubMed ID: 10697982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.
    Sasaki H; Hayakawa J; Terai Y; Kanemura M; Tanabe-Kimura A; Kamegai H; Seino-Noda H; Ezoe S; Matsumura I; Kanakura Y; Sakata M; Tasaka K; Ohmichi M
    Oncogene; 2008 Apr; 27(19):2737-45. PubMed ID: 18193094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of estrogen and selective estrogen receptor modulators in anti-aging].
    Ohta H
    Clin Calcium; 2008 Jul; 18(7):986-94. PubMed ID: 18591752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SERMs and cardiovascular disease in women. How do these agents affect risk?
    Bush TL; Blumenthal R; Lobo R; Clarkson TB
    Postgrad Med; 2001 Mar; Spec No():17-24. PubMed ID: 11296735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Additional effect of SERM: central nervous system].
    Honjo H
    Clin Calcium; 2004 Oct; 14(10):69-72. PubMed ID: 15577134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective estrogen receptor modulators: an update on recent clinical findings.
    Shelly W; Draper MW; Krishnan V; Wong M; Jaffe RB
    Obstet Gynecol Surv; 2008 Mar; 63(3):163-81. PubMed ID: 18279543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen, raloxifene and the prevention of breast cancer.
    Bentrem DJ; Craig Jordan V
    Minerva Endocrinol; 2002 Jun; 27(2):127-39. PubMed ID: 11961504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of oestrogen receptor-active compounds on lipid metabolism.
    Lakoski SG; Herrington DM
    Diabetes Obes Metab; 2005 Sep; 7(5):471-7. PubMed ID: 16050939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of selective estrogen receptor modulator (SERM) action.
    Dutertre M; Smith CL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):431-7. PubMed ID: 11046073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the sexual function and quality of life in raloxifene treated postmenopausal women.
    Biri A; Korucuoglu U; Ilhan MN; Ciftci B; Bozkurt N; Guner H
    Arch Gynecol Obstet; 2009 Apr; 279(4):505-9. PubMed ID: 18690468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis].
    Iwamoto J
    Clin Calcium; 2010 Mar; 20(3):396-407. PubMed ID: 20190370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Selective estrogen receptor modulators (SERMs)].
    Matsumoto T
    Clin Calcium; 2006 Sep; 16(9):1520-25. PubMed ID: 16951478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Selective estrogen-receptor modulators (SERM's) in postmenopausal women].
    Hart W; Netelenbos JC
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1771-6. PubMed ID: 10494328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of raloxifene as a SERM on bone metabolism].
    Ohta H
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():411-8. PubMed ID: 16689343
    [No Abstract]   [Full Text] [Related]  

  • 37. Recent advances in the synthesis of raloxifene: a selective estrogen receptor modulator.
    Dadiboyena S
    Eur J Med Chem; 2012 May; 51():17-34. PubMed ID: 22405286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Selective estrogen receptor modulator (SERM)].
    Inoue D; Matsumoto T
    Nihon Rinsho; 2005 Mar; 63 Suppl 3():613-8. PubMed ID: 15813137
    [No Abstract]   [Full Text] [Related]  

  • 39. Divergent responsiveness of the dentary and vertebral bone to a selective estrogen-receptor modulator (SERM) in the teleost Sparus auratus.
    Vieira FA; Pinto PI; Guerreiro PM; Power DM
    Gen Comp Endocrinol; 2012 Dec; 179(3):421-7. PubMed ID: 23036732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of SERMs on bone health. SERM and metabolic markers of bone].
    Takami M; Shimada H
    Clin Calcium; 2010 Mar; 20(3):365-71. PubMed ID: 20190366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.